Valeant (NYSE: VRX) Stock Price Drops 9% as "Pharma's Enron" Fails to Calm Investors

The Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock price dropped another 9% to $106.03 Monday morning. The drop happened as "pharma's Enron" tried to calm investors with an analyst conference that defended the firm's business and dealings. The Valeant stock price is now down more than 56% since early August. And the troubles are far from over for VRX stock.... Tags: NYSE: VRX , pharmaceutical Enron , Valeant , Valeant Enron , Valeant shares , Valeant stock , Valeant stock drop , Valeant stock price today , VRX stock , VRX stock drop , VRX stock price To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Valeant (NYSE: VRX) Stock Price Drops 9% as "Pharma's Enron" Fails to Calm Investors appeared first on Money Morning - We Make Investing Profitable .